A hemoconcentrator is a
device used for removal of fluid during cardio bypass surgery.
Hemoconcentrators are introduced in extracorpeal circuit where it controls
hemodilution, maintains hematocrit levels, and reduces the need for additional
blood products during and after surgery. Hemoconcentrators are widely used
during cardiac bypass surgery and has become the ideal method for controlling
hemodilution during cardiopulmonary surgery by surgeons and perfusionists.
High prevalence of
cardiovascular diseases is expected to lead to high demand for hemoconcentrators
and thus drive the adult and pediatric hemoconcentrators market growth
Hemoconcentrators are
widely used devices during cardio bypass surgery. High prevalence of
cardiovascular diseases is expected to be a major factor propelling demand for
hemoconcentrator. According to the data published by World Health Organization
(WHO) in 2017, cardiovascular diseases is the leading cause of death globally.
Annually, more people die from cardiovascular diseases than from any other
cause.
According to the data
published by World Health Organization (WHO) in 2018, an estimated around 17.7
million people died from cardiovascular diseases in 2015, representing 31% of
all global deaths. Such high prevalence of cardiovascular diseases is expected
to lead to high demand for hemoconcentrators and drive global adult and
pediatric hemoconcentrators market growth over the forecast period.
Key players in the market
include Terumo Corporation, LivaNova Plc., Medtronic Plc., etc. All these key
players manufacture and market their own novel hemoconcentrators developed from
different materials with different advantages. For instance, in 2011 Minntech
Corporation (a Cantel Medical Corporation company) introduced The Hemocor HPH
Hemoconcentrator made with Eastman Chemical Company’s Tritan Copolyester.
Tritan is a new-generation copolyester that offers the benefits of toughness,
chemical resistance, and color stability after sterilization for renal medical
device housings.
The global adult and pediatric
hemoconcentrators market size was valued at US$ 10.7 Mn in 2017, and is
expected to witness a CAGR of 3.3% during the forecast period (2018 – 2026).
North America is expected
to hold dominant position in the market, owing to frequent approvals of new
adult and pediatric hemoconcentrators by regulatory bodies
North America is expected
to hold dominant position in global adult and pediatric hemoconcentrators
market over the forecast period, owing to high prevalence of cardiovascular
diseases in the U.S. and rising healthcare awareness in region.
Comments
Post a Comment